The results indicated that PANDAR expression was significantly associated with clinicopathological parameters of GC, such as pathological differentiation and TNM stage (P < 0.05), which is suggested that it may be a potential marker of liquid biopsy [17]. This evidence concerns the gene PANDAR and gastric cancer.